{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:14:51Z","timestamp":1759335291372},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.1001\/jamadermatol.2021.4634","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T16:00:52Z","timestamp":1638979252000},"page":"13","source":"Crossref","is-referenced-by-count":2,"title":["It Is Time to Focus on Pustular Psoriasis"],"prefix":"10.1001","volume":"158","author":[{"given":"Edward W.","family":"Cowen","sequence":"first","affiliation":[{"name":"Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"ded210017r1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa2102388","article-title":"Bimekizumab versus adalimumab in plaque psoriasis.","volume":"385","author":"Warren","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"ded210017r2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis.","volume":"385","author":"Reich","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"ded210017r3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"ded210017r4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/jdv.12773","article-title":"Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis.","volume":"29","author":"Saeki","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"ded210017r5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bjd.14702","article-title":"Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study.","volume":"176","author":"Yamasaki","year":"2017","journal-title":"Br J Dermatol"},{"issue":"10","key":"ded210017r6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/jamadermatol.2019.1394","article-title":"Efficacy and safety of guselkumab in Japanese patients with palmoplantar pustulosis: a phase 3 randomized clinical trial.","volume":"155","author":"Terui","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"23","key":"ded210017r7","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"ded210017r8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"ded210017r9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jaci.2014.09.043","article-title":"IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis.","volume":"135","author":"Hussain","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"ded210017r10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.","volume":"140","author":"Johnston","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"ded210017r11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bjd.15867","article-title":"The genetic basis for most patients with pustular skin disease remains elusive.","volume":"178","author":"M\u00f6ssner","year":"2018","journal-title":"Br J Dermatol"},{"issue":"11","key":"ded210017r12","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist.","volume":"133","author":"Sugiura","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ded210017r13","article-title":"Evaluation of a case series of patients with palmoplantar pustulosis in the United States.","author":"Noe","journal-title":"JAMA Dermatol"},{"key":"ded210017r14","article-title":"Evaluation of a case series of patients with generalized pustular psoriasis in the United States.","author":"Noe","journal-title":"JAMA Dermatol"},{"issue":"10","key":"ded210017r15","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1016\/j.jid.2021.08.089","article-title":"International Rare and Severe Psoriasis Expert Network (IRASPEN)\u2014a prospective multi-centre pustular psoriasis registry with genotype-phenotype correlation","volume":"141","author":"Maul","year":"2021","journal-title":"J Invest Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2786978\/jamadermatology_cowen_2021_ed_210017_1641397682.71984.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T16:02:18Z","timestamp":1642608138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2786978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.4634","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}